Rational drug design of CB2 receptor ligands: from 2012 to 2021.

Wu, Yan-Ran; Tang, Jia-Qin; Zhang, Wan-Nian; Zhuang, Chun-Lin; Shi, Ying

Wu, Yan-Ran; Tang, Jia-Qin; Zhang, Wan-Nian; Zhuang, Chun-Lin; Shi, Ying.

Afiliação

Wu YR; School of Pharmacy, Key Laboratory of Hui Ethnic Medicine Modernization, Ministry of Education, Ningxia Medical University 1160 Shengli Street Yinchuan 750004 China nxshiying@163.com.
Tang JQ; School of Pharmacy, Key Laboratory of Hui Ethnic Medicine Modernization, Ministry of Education, Ningxia Medical University 1160 Shengli Street Yinchuan 750004 China nxshiying@163.com.
Zhang WN; School of Pharmacy, Key Laboratory of Hui Ethnic Medicine Modernization, Ministry of Education, Ningxia Medical University 1160 Shengli Street Yinchuan 750004 China nxshiying@163.com.
Zhuang CL; School of Pharmacy, Second Military Medical University 325 Guohe Road Shanghai 200433 China.
Shi Y; School of Pharmacy, Key Laboratory of Hui Ethnic Medicine Modernization, Ministry of Education, Ningxia Medical University 1160 Shengli Street Yinchuan 750004 China nxshiying@163.com.

RSC Adv ; 12(54): 35242-35259, 2022 Dec 06.

Article em En | MEDLINE | ID: mdl-36540233

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: RSC Adv Ano de publicação: 2022 Tipo de documento: Article